Literature DB >> 20237344

Performance of common genetic variants in breast-cancer risk models.

Sholom Wacholder1, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft, Bernard Rosner, Christine D Berg, Louise A Brinton, Jolanta Lissowska, Mark E Sherman, Rowan Chlebowski, Charles Kooperberg, Rebecca D Jackson, Dennis W Buckman, Peter Hui, Ruth Pfeiffer, Kevin B Jacobs, Gilles D Thomas, Robert N Hoover, Mitchell H Gail, Stephen J Chanock, David J Hunter.   

Abstract

BACKGROUND: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown.
METHODS: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case-control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model.
RESULTS: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile.
CONCLUSIONS: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information. 2010 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2010        PMID: 20237344      PMCID: PMC2921181          DOI: 10.1056/NEJMoa0907727

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  27 in total

Review 1.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Authors:  M H Gail; J P Costantino; J Bryant; R Croyle; L Freedman; K Helzlsouer; V Vogel
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

2.  Moderate alcohol consumption and the risk of breast cancer.

Authors:  W C Willett; M J Stampfer; G A Colditz; B A Rosner; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1987-05-07       Impact factor: 91.245

3.  Validation studies on a model for breast cancer risk.

Authors:  M H Gail; J Benichou
Journal:  J Natl Cancer Inst       Date:  1994-04-20       Impact factor: 13.506

4.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

5.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

Authors:  R B Hayes; D Reding; W Kopp; A F Subar; N Bhat; N Rothman; N Caporaso; R G Ziegler; C C Johnson; J L Weissfeld; R N Hoover; P Hartge; C Palace; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

6.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

7.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

8.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

9.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.

Authors:  Robert D Langer; Emily White; Cora E Lewis; Jane M Kotchen; Susan L Hendrix; Maurizio Trevisan
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

10.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

View more
  213 in total

1.  Evaluating breast cancer risk projections for Hispanic women.

Authors:  Matthew P Banegas; Mitchell H Gail; Andrea LaCroix; Beti Thompson; Maria Elena Martinez; Jean Wactawski-Wende; Esther M John; F Allan Hubbell; Shagufta Yasmeen; Hormuzd A Katki
Journal:  Breast Cancer Res Treat       Date:  2011-12-07       Impact factor: 4.872

2.  What is a functional locus? Understanding the genetic basis of complex phenotypic traits.

Authors:  Edward A Ruiz-Narváez
Journal:  Med Hypotheses       Date:  2011-02-01       Impact factor: 1.538

3.  Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons.

Authors:  Bhramar Mukherjee; Jaeil Ahn; Stephen B Gruber; Nilanjan Chatterjee
Journal:  Am J Epidemiol       Date:  2011-12-22       Impact factor: 4.897

4.  Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Authors:  Jie Lin; Charles Lu; David J Stewart; Jian Gu; Maosheng Huang; David W Chang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

5.  Multilevel research and the challenges of implementing genomic medicine.

Authors:  Muin J Khoury; Ralph J Coates; Mary L Fennell; Russell E Glasgow; Maren T Scheuner; Sheri D Schully; Marc S Williams; Steven B Clauser
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

6.  Comment on "the predictive capacity of personal genome sequencing".

Authors:  Colin B Begg; Malcolm C Pike
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

Review 7.  Personalized medicine: hope or hype?

Authors:  Keyan Salari; Hugh Watkins; Euan A Ashley
Journal:  Eur Heart J       Date:  2012-06-01       Impact factor: 29.983

8.  Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases.

Authors:  Hugues Aschard; Jinbo Chen; Marilyn C Cornelis; Lori B Chibnik; Elizabeth W Karlson; Peter Kraft
Journal:  Am J Hum Genet       Date:  2012-05-24       Impact factor: 11.025

9.  Two-stage breast cancer screening in the developing world.

Authors:  Charalabos Batsis
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

10.  BAYESIAN SEMIPARAMETRIC ANALYSIS FOR TWO-PHASE STUDIES OF GENE-ENVIRONMENT INTERACTION.

Authors:  Jaeil Ahn; Bhramar Mukherjee; Stephen B Gruber; Malay Ghosh
Journal:  Ann Appl Stat       Date:  2013-03       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.